Bio company Orum Therapeutics announced on the 29th that it will withdraw its planned listing on the KOSDAQ market next month and will reschedule its initial public offering (IPO) for next year.
Orum Therapeutics had been preparing for the listing, including submitting a securities registration statement, until recently.
Lee Seung-joo, CEO of Orum Therapeutics, stated, "Considering the current market conditions, we judged that postponing the planned listing schedule is in the best interest of all stakeholders," adding, "We will continue to do our best to fulfill our mission of developing innovative new drugs for patients in need of treatment."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
